{"id":"W2128450617","doi":"10.1136/thoraxjnl-2013-203600","title":"Once-daily fluticasone furoate (FF)/vilanterol reduces risk of severe exacerbations in asthma versus FF alone","year":2013,"lang":"en","type":"article","venue":"Thorax","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University","funders":"National Institute for Health and Care Research; Teva Pharmaceutical Industries; Sanofi; Wake Forest University; Amgen; Pfizer; Genentech; AstraZeneca; UCB Pharma; American Academy of Allergy Asthma and Immunology; GlaxoSmithKline","keywords":"Medicine; Fluticasone propionate; Asthma; Exacerbation; Adverse effect; Corticosteroid; Internal medicine; Fluticasone; Clinical endpoint; Mometasone furoate; Rate ratio; Evening; Anesthesia; Randomized controlled trial; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001477528,0.0001744125,0.0003710279,0.0001487345,0.00006274787,0.0000163894,0.0001177782,0.0001009616,0.0008865631],"category_scores_gemma":[0.0001703523,0.0001408223,0.0001055719,0.0002874724,0.0001477442,0.0001455944,0.00004198601,0.0002157053,0.0003966677],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004958464,"about_ca_system_score_gemma":0.0001239628,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002300661,"about_ca_topic_score_gemma":0.00003740396,"domain_scores_codex":[0.9986846,0.0001324377,0.0003546054,0.0002623189,0.0002765949,0.0002894459],"domain_scores_gemma":[0.9990537,0.0001201238,0.0001407973,0.0003557503,0.0001239078,0.0002057523],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.009869325,0.004617331,0.3479499,0.0009918187,0.001062307,0.0006453941,0.007352472,0.0008626341,0.1614045,0.0003339966,0.06526928,0.3996411],"study_design_scores_gemma":[0.009487089,0.002186197,0.9611956,0.0005842365,0.000339003,0.00005852289,0.004342507,0.001129587,0.0111996,0.0001957064,0.008767121,0.0005148104],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.993403,0.001160353,0.00002743324,0.0004458566,0.0001709985,0.0004471131,0.00005376917,0.00005992447,0.004231507],"genre_scores_gemma":[0.9979272,0.0001529805,0.0004681157,0.0001013866,0.0001565332,0.00004417963,0.00002706464,0.00002547624,0.0010971],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6132457,"threshold_uncertainty_score":0.9707245,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01786435224473766,"score_gpt":0.2812869307063584,"score_spread":0.2634225784616207,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}